Literature DB >> 16718707

Ibuprofen and the mouse model of Parkinson's disease.

Iwona Kurkowska-Jastrzebska, Andrzej Członkowski, Anna Członkowska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16718707     DOI： 10.1002/ana.20860

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  Use of ibuprofen and risk of Parkinson disease.

Authors:  Xiang Gao; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2011-03-02       Impact factor: 9.910

2.  Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration.

Authors:  Ashish Singh; Pratibha Tripathi; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2015-12-12       Impact factor: 5.590

Review 3.  NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

Authors:  Ali Samii; Mahyar Etminan; Matthew O Wiens; Siavash Jafari
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Francesca L'Episcopo; Cataldo Tirolo; Salvatore Caniglia; Nunzio Testa; Pier A Serra; Francesco Impagnatiello; Maria C Morale; Bianca Marchetti
Journal:  J Neuroinflammation       Date:  2010-11-23       Impact factor: 8.322
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.